# Abbott Medical - VERITAS Study

Study · id `cardio:ct-nct06707688` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06707688](<https://clinicaltrials.gov/study/NCT06707688>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06707688

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 458 participants.

## Technical summary

Registry record NCT06707688. Allocation not applicable; no masking; primary purpose treatment. Start 2024-11-07 (actual); primary completion 2025-11-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 458 participants (enrolled count; ClinicalTrials.gov record NCT06707688, source copy `cardio:ctgov-nct06707688-2026-08-04`, retrieved 2026-11-18)
- Started: 2024-11-07 (actual) (ClinicalTrials.gov record NCT06707688, source copy `cardio:ctgov-nct06707688-2026-08-04`, retrieved 2026-11-18)
- Primary completion: 2025-11-06 (actual) (ClinicalTrials.gov record NCT06707688, source copy `cardio:ctgov-nct06707688-2026-08-04`, retrieved 2026-11-18)
- Completion: 2027-09 (anticipated) (ClinicalTrials.gov record NCT06707688, source copy `cardio:ctgov-nct06707688-2026-08-04`, retrieved 2026-11-18)
- Countries: United States; Belgium; Canada; Denmark; France; Germany; Italy; Spain; Switzerland (ClinicalTrials.gov record NCT06707688, source copy `cardio:ctgov-nct06707688-2026-08-04`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06707688-2026-08-04`, retrieved 2026-11-18)

## The registry's words

- Brief title: Abbott Medical - VERITAS Study
- Condition: Atrial Fibrillation (AF)
- Condition: Stoke
- Intervention (Device): Amulet™ 2 Left Atrial Appendage (LAA) Occluder
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: e53cff176883a98fae63e49ccca2c719b637c36623c71ba0bbfd64feaba5c7ac
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
